Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Jun. 2026,
Chiang Mai Ram Medical Business PCL paid฿0 Mil more to buy back shares than it received from issuing new shares.
It spent฿45 Mil paying down its debt.
It paid฿0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spent฿0 Mil paying cash dividends to shareholders.
It spent฿20 Mil on other financial activities.
In all, Chiang Mai Ram Medical Business PCLspent฿65 Mil on financial activities for the
three
months ended in Jun. 2026.
Chiang Mai Ram Medical Business PCL (BKK:CMR) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Chiang Mai Ram Medical Business PCL's issuance of stock for the
three
months ended in Jun. 2026 was ฿0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Chiang Mai Ram Medical Business PCL's repurchase of stock for the
three
months ended in Jun. 2026 was ฿0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Chiang Mai Ram Medical Business PCL's net issuance of debt for the
three
months ended in Jun. 2026 was ฿-45 Mil.
Chiang Mai Ram Medical Business PCL spent฿45 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Chiang Mai Ram Medical Business PCL's net issuance of preferred for the
three
months ended in Jun. 2026 was ฿0 Mil.
Chiang Mai Ram Medical Business PCL paid฿0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Chiang Mai Ram Medical Business PCL's cash flow for dividends for the
three
months ended in Jun. 2026 was ฿-0 Mil.
Chiang Mai Ram Medical Business PCL spent฿0 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Chiang Mai Ram Medical Business PCL's other financing for the
three
months ended in Jun. 2026 was ฿-20 Mil.
Chiang Mai Ram Medical Business PCL spent฿20 Mil on other financial activities.
Chiang Mai Ram Medical Business PCL Cash Flow from Financing Related Terms
Chiang Mai Ram Medical Business PCL Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiang Mai Ram Medical Business PCL Cash Flow from Financing Chart
Chiang Mai Ram Medical Business PCL Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-1,779 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of ฿-1,779 Mil mean?
Chiang Mai Ram Medical Business PCL (BKK:CMR) has a Cash Flow from Financing of ฿-1,779 Mil as of Jun. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Chiang Mai Ram Medical Business PCL and its competitors.
Is Chiang Mai Ram Medical Business PCL's Cash Flow from Financing too high?
Chiang Mai Ram Medical Business PCL's current Cash Flow from Financing is ฿-1,779 Mil. Overall, Chiang Mai Ram Medical Business PCL has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chiang Mai Ram Medical Business PCL's Cash Flow from Financing compare to HCA and THC?
Chiang Mai Ram Medical Business PCL's Cash Flow from Financing of ฿-1,779 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Chiang Mai Ram Medical Business PCL and its competitors. Chiang Mai Ram Medical Business PCL's current Cash Flow from Financing is ฿-1,779 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chiang Mai Ram Medical Business PCL stock overvalued right now?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL (BKK:CMR) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿0.54, compared to a current price of ฿1.31 — trading 142.6% above its estimated fair value. The current Cash Flow from Financing is ฿-1,779 Mil. Chiang Mai Ram Medical Business PCL's overall GF Score™ is 37/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Chiang Mai Ram Medical Business PCL (BKK:CMR), the current Cash Flow from Financing is ฿-1,779 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chiang Mai Ram Medical Business PCL (BKK:CMR) Overvalued in 2026?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL stock appears to be overvalued.
The current stock price of ฿1.31 is trading 142.6% above its estimated GF Value™ of ฿0.54.
GuruFocus considers Chiang Mai Ram Medical Business PCL to be Significantly Overvalued.
Key valuation signals for BKK:CMR:
Cash Flow from Financing: ฿-1,779 Mil
GF Value™: ฿0.54 vs. price of ฿1.31 (142.6% above fair value)
No single metric tells the full story. See the BKK:CMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chiang Mai Ram Medical Business PCL is a Thailand-based company. It provides medical services in the nature of General Hospital, Hospital in Social Security, and the national health security office systems. It offers various medical services including a Dental center, X-ray mobile for a checkup, CT Multislice, Cardiac Catheterization Center, Back pain center, Gynecologic Cancer center, Physical therapy, Operating theatres, Laboratory, Ambulance Services, and Health checkup center, and others. The company provides medical services through the Lanna Hospital.
37GF Score
Get the complete analysis for BKK:CMR
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CMR has been successfully added to your 
